Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23904 | 23394096 | Curr Pharm Des | Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD. | 2013 | Details |
| A23908 | 23394092 | Curr Pharm Des | Pathophysiology of NASH: perspectives for a targeted treatment. | 2013 | Details |
| A23909 | 23394091 | Curr Pharm Des | Epidemiology and natural history of patients with NAFLD. | 2013 | Details |
| A23916 | 23390892 | Atherosclerosis | Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease. | 2013 | Details |
| A23918 | 23390127 | Hepatology | Dietary fructose in nonalcoholic fatty liver disease. | 2013 | Details |
| A23936 | 23373292 | Vopr Kurortol Fizioter Lech Fiz Kult | [Balneotherapeutics of non-alcoholic fatty liver disease with the use of the Essentuki-type drinking mineral waters]. | 2013 | Details |
| A23939 | 23370355 | Biol Pharm Bull | A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis. | 2013 | Details |
| A23941 | 23369196 | Clin Exp Pharmacol Physiol | Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men. | 2013 | Details |
| A23943 | 23367495 | J Clin Res Pediatr Endocrinol | Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. | 2013 | Details |
| A23944 | 23367494 | J Clin Res Pediatr Endocrinol | High-sensitivity C-reactive protein levels and metabolic disorders in obese and overweight children and adolescents. | 2013 | Details |
| A23946 | 23363012 | Ann N Y Acad Sci | Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. | 2013 | Details |
| A23952 | 23355910 | World J Hepatol | Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome? | 2012 | Details |
| A23955 | 23353640 | Clin Gastroenterol Hepatol | External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. | 2013 | Details |
| A23962 | 23348005 | Toxicol In Vitro | Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. | 2013 | Details |
| A23967 | 23346097 | Front Genet | Molecular Interactions between NAFLD and Xenobiotic Metabolism. | 2013 | Details |
| A23968 | 23344895 | Pediatr Cardiol | Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
| A23969 | 23340336 | Br J Nutr | Carbohydrate quality is not associated with liver enzyme activity and plasma TAG and HDL concentrations over 5 years in an older population. | 2013 | Details |
| A23972 | 23334462 | Diabetologia | Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3. | 2013 | Details |
| A23975 | 23332087 | Hepatol Res | Liver and diabetes. A vicious circle. | 2013 | Details |
| A23978 | 23329754 | J Pediatr Endocrinol Metab | A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents. | 2012 | Details |
| A23979 | 23329465 | Drugs | Nonalcoholic fatty liver disease: current issues and novel treatment approaches. | 2013 | Details |
| A23989 | 23324907 | Herz | Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. | 2013 | Details |
| A23994 | 23320150 | J Obes | Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? | 2012 | Details |
| A23995 | 23320041 | Evid Based Complement Alternat Med | Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome. | 2012 | Details |
| A24003 | 23312215 | J Diabetes Complications | Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. | 2013 | Details |
| A24007 | 23305008 | Klin Lab Diagn | [The unity of pathogenesis of insulin resistance syndrome and non-alcoholic fatty disease of liver. The metabolic disorder of fatty acids and triglycerides]. | 2012 | Details |
| A24008 | 23304532 | Int J Hepatol | Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease. | 2012 | Details |
| A24009 | 23304464 | J Obes | The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome. | 2012 | Details |
| A24017 | 23299992 | Hepatology | Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. | 2013 | Details |
| A24020 | 23298957 | Curr Opin Lipidol | Perspective: nonalcoholic fatty liver disease and cardiovascular risk. | 2013 | Details |
| A24026 | 23295007 | Psychosomatics | Association of chronic liver disease with depression: a population-based study. | 2013 | Details |
| A24027 | 23294957 | Chirurgia (Bucur) | Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. | 2013 | Details |
| A24032 | 23293330 | J Clin Endocrinol Metab | Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. | 2013 | Details |
| A24033 | 23293250 | BMJ Open | Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study. | 2013 | Details |
| A24037 | 23293196 | Ann Hepatol | Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. | 2013 | Details |
| A24043 | 23286927 | Nutr Clin Pract | Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. | 2013 | Details |
| A24045 | 23285761 | Klin Med (Mosk) | [The prevalence of liver and gallbladder pathologies in overweight and obese patients]. | 2012 | Details |
| A24051 | 23278318 | Diabet Med | Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population. | 2013 | Details |
| A24055 | 23274901 | Diabetes | Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism. | 2012 | Details |
| A24056 | 23273500 | Clin Res Hepatol Gastroenterol | Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A24065 | 24688728 | Comput Struct Biotechnol J | The Role of INDY in Metabolic Regulation. | 2013 | Details |
| A24066 | 24648896 | Biomed Rep | Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model. | 2012 | Details |
| A24067 | 24648894 | Biomed Rep | Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2012 | Details |
| A24072 | 23266468 | Diabetes Metab | Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. | 2012 | Details |
| A24076 | 23260104 | J Pediatr | Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. | 2012 | Details |
| A24078 | 23258548 | Mol Pharmacol | 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model. | 2012 | Details |
| A24079 | 23258240 | Recenti Prog Med | [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation]. | 2012 | Details |
| A24085 | 23239917 | World J Gastroenterol | Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease? | 2012 | Details |
| A24086 | 23238855 | Endocr Rev | Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. | 2012 | Details |
| A24091 | 23236229 | World J Gastroenterol | Way back for fructose and liver metabolism: bench side to molecular insights. | 2012 | Details |
| A24093 | 23234816 | Hepatogastroenterology | Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. | 2012 | Details |
| A24094 | 23234151 | Zhongguo Zhong Yao Za Zhi | [Clinical study on prevention efficacy of Jianpi Huatan Fang in treating non-alcoholic fatty liver disease in children]. | 2012 | Details |
| A24102 | 23227347 | Int J Hepatol | Posttransplant metabolic syndrome. | 2012 | Details |
| A24104 | 23227248 | PLoS One | Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. | 2012 | Details |
| A24111 | 23221052 | Nihon Shokakibyo Gakkai Zasshi | [Clinical characteristics of non-alcoholic steatohepatitis (NASH) patients who progressed from F3 stage fibrosis to cirrhotic NASH]. | 2012 | Details |
| A24112 | 23220074 | Nutr Metab Cardiovasc Dis | Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children. | 2012 | Details |
| A24135 | 25755455 | J Clin Exp Hepatol | A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis. | 2012 | Details |
| A24141 | 23185203 | Arch Med Sci | Metformin and its clinical use: new insights for an old drug in clinical practice. | 2012 | Details |
| A24145 | 23182413 | Epilepsy Res | The novel insulin resistance parameters RBP4 and GLP-1 in patients treated with valproic acid: just a sidestep? | 2012 | Details |
| A24146 | 23179302 | Clin Exp Med | Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. | 2012 | Details |
| A24154 | 23174781 | Hepatology | Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway. | 2013 | Details |
| A24162 | 23165534 | Nutr Hosp | Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease. | 2013 | Details |
| A24165 | 23159641 | Life Sci | Nonalcoholic fatty liver disease: current and potential therapies. | 2012 | Details |
| A24166 | 23158933 | Fertil Steril | Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. | 2012 | Details |
| A24174 | 23148186 | Ther Adv Endocrinol Metab | An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD). | 2011 | Details |
| A24179 | 23143735 | Dig Dis Sci | Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. | 2012 | Details |
| A24186 | 23141876 | Int J Cardiol | Non-alcoholic fatty liver disease and cardiovascular risk. | 2012 | Details |
| A24201 | 23127227 | Clin Exp Pharmacol Physiol | Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway. | 2012 | Details |
| A24211 | 23117851 | Medicine (Baltimore) | Nonalcoholic fatty liver disease in lean individuals in the United States. | 2012 | Details |
| A24214 | 23113121 | Iran J Public Health | Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults. | 2012 | Details |
| A24218 | 23110104 | PLoS One | E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. | 2012 | Details |
| A24220 | 23110056 | PLoS One | Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults. | 2012 | Details |
| A24222 | 23108199 | Curr Opin Endocrinol Diabetes Obes | Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. | 2012 | Details |
| A24227 | 23092327 | Curr Pharm Des | Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A24228 | 23091922 | Rev Med Brux | [Non alcoholic fatty liver disease assessment]. | 2012 | Details |
| A24235 | 23091808 | Clin Mol Hepatol | Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH. | 2012 | Details |
| A24238 | 23087748 | Hepat Mon | Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study. | 2012 | Details |
| A24239 | 23087670 | Front Neurol | Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? | 2012 | Details |
| A24245 | 23081825 | Hepatology | Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. | 2013 | Details |
| A24247 | 23078137 | Eur J Clin Invest | Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma. | 2012 | Details |
| A24249 | 23077135 | Gut | Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24256 | 23070083 | J Physiol Pharmacol | A novel pathophysiological-based panel of biomarkers for the diagnosis of nonalcoholic steatohepatitis. | 2012 | Details |
| A24262 | 23066331 | World J Gastroenterol | Vague relationship between alcohol consumption and metabolic syndrome in nonobese people. | 2012 | Details |
| A24263 | 23066121 | J Clin Endocrinol Metab | Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. | 2012 | Details |
| A24266 | 23065020 | J Gastroenterol | The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. | 2012 | Details |
| A24273 | 23059409 | J Clin Gastroenterol | Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. | 2013 | Details |
| A24275 | 23057494 | Aliment Pharmacol Ther | Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. | 2012 | Details |
| A24279 | 23042833 | Nutr Clin Pract | Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease. | 2012 | Details |
| A24281 | 23042372 | Minerva Med | Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. | 2012 | Details |
| A24288 | 23036645 | Metabolism | Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. | 2012 | Details |
| A24295 | 23031808 | Gene | Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India. | 2012 | Details |
| A24298 | 23028442 | PLoS One | Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. | 2012 | Details |
| A24301 | 23025244 | J Med Chem | Synthesis and biological evaluation of 5-benzylidenepyrimidine-2,4,6(1H,3H,5H)-trione derivatives for the treatment of obesity-related nonalcoholic fatty liver disease. | 2012 | Details |
| A24306 | 23022226 | Biochem Pharmacol | High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload. | 2012 | Details |
| A24310 | 23018041 | Nutr Metab Cardiovasc Dis | Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. | 2012 | Details |
| A24311 | 23014486 | J Nutr | Opuntia ficus indica (nopal) attenuates hepatic steatosis and oxidative stress in obese Zucker (fa/fa) rats. | 2012 | Details |
| A24316 | 23006461 | Saudi J Gastroenterol | Serum TGF-β, Serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD. | 2013 | Details |
| A24318 | 23001964 | Pediatr Obes | The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk? | 2012 | Details |
| A24320 | 23000278 | Appetite | Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease. | 2012 | Details |
| A24322 | 22999247 | Heart Fail Clin | Hepatic and cardiac steatosis: are they coupled? | 2012 | Details |